ACLS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Westhuyzen, J.
Right arrow Articles by Stanbury, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Westhuyzen, J.
Right arrow Articles by Stanbury, V.
Annals of Clinical & Laboratory Science 33:3-10 (2003)
© 2003 Association of Clinical Scientists

Oxidative Stress and Erythrocyte Integrity in End-Stage Renal Failure Patients Hemodialysed Using a Vitamin E-Modified Membrane

Justin Westhuyzen1, David Saltissi2 and Veronica Stanbury2
1 Conjoint Renal Laboratory, Queensland Health Pathology Service, Royal Brisbane Hospital, and
2 Department of Renal Medicine, Royal Brisbane Hospital, Brisbane, Queensland, Australia

Address correspondence to Justin Westhuyzen, Ph.D., Conjoint Renal Laboratory, Royal Brisbane Hospital Research Foundation, Bancroft Centre, Herston 4029, Queensland, Australia; tel 617 3636 1084; fax 617 3636 1084, e-mail justin_westhuyzen{at}health.qld.gov.au.

Oxidative stress has been implicated in a range of disease states, including end-stage renal failure treated with hemodialysis. Hemodialysis with vitamin E-modified membranes reduces lipid peroxidation, but the effect on erythrocyte integrity has not been determined. This study compared antioxidant defense parameters and the resistance of erythrocytes to free radical-mediated hemolysis in patients dialysed with cellulose acetate membranes at baseline and with a vitamin E-modified membrane (Excebrane Clirans; Terumo Corporation) for 13 wk. Resistance of erythrocytes to free radical attack was assessed in vitro using the peroxyl hemolysis test. The time to 50% hemolysis (T50%) increased significantly during the first 6 wk of Excebrane use (p <0.05), but this parameter returned to baseline by 13 wk. Glutathione concentration and erythrocyte superoxide dismutase activity were unchanged during the study, but glutathione peroxidase activity increased from low levels at baseline and became significantly higher at 6 and 13 wk (p <0.001). Total erythrocyte polyunsaturated fatty acid content and C18:2 level increased (p <0.001) and saturated fatty acids (total, C16:0, C18:0, C22:0 and C24:0) decreased (p <0.03). Total monounsaturated fatty acid content was unchanged. The increased resistance of erythrocytes to hemolysis, the increased glutathione peroxidase activity, and the increased degree of unsaturation of fatty acids in the erythrocyte membrane are compatible with a reduction of oxidative stress during hemodialysis with vitamin E-modified membranes.

Keywords: vitamin E, lipoperoxidation, glutathione, erythrocytes, fatty acids, superoxide dismutase, glutathione peroxidase, peroxyl hemolysis test, dialysis membranes







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the Association of Clinical Scientists.